3//SEC Filing
AbbVie Inc. 3
Accession 0001104659-25-067472
$ABBVCIK 0001551152operating
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 6:20 PM ET
Size
12.0 KB
Accession
0001104659-25-067472
Insider Transaction Report
Form 3
AbbVie Inc.ABBV
AbbVie Inc.
EVP, Chief HR Officer
Holdings
Option (Right to buy)
Exercise: $192.86Exp: 2035-02-12→ Common Stock (4,687 underlying)Option (Right to buy)
Exercise: $175.28Exp: 2034-02-14→ Common Stock (5,043 underlying)- 7,048
Common stock, $0.01 par value
Footnotes (3)
- [F1]Includes 1,113 restricted stock units granted under the AbbVie Amended and Restated 2013 Incentive Stock Program. These restricted stock units vest in full on February 16, 2026, and include the right to have stock withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 1,681 shares on 2/15/2025, and will become exercisable as to 1,681 shares on 2/15/2026 and as to 1,681 shares on 2/16/2027.
- [F3]Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option will become exercisable as to 1,563 shares on 2/13/2026, as to 1,562 shares on 2/13/2027 and as to 1,562 shares on 2/13/2028.
Issuer
AbbVie Inc.
CIK 0001551152
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001551152
Filing Metadata
- Form type
- 3
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 6:20 PM ET
- Size
- 12.0 KB